Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.
about
Subversion of Host Innate Immunity by Uropathogenic Escherichia coliMechanisms of pain from urinary tract infectionIn silico design of fusion protein of FimH from uropathogenic Escherichia coli and MrpH from Proteus mirabilis against urinary tract infectionsO-antigen modulates infection-induced pain states.Tobacco upregulates P. gingivalis fimbrial proteins which induce TLR2 hyposensitivity.Waging war against uropathogenic Escherichia coli: winning back the urinary tractHost-pathogen interactions mediating pain of urinary tract infection.Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccineIn vivo mRNA profiling of uropathogenic Escherichia coli from diverse phylogroups reveals common and group-specific gene expression profilesGenome-wide analysis of the Pho regulon in a pstCA mutant of Citrobacter rodentium.Asymptomatic bacteriuria Escherichia coli are live biotherapeutics for UTI.Necrosis is the dominant cell death pathway in uropathogenic Escherichia coli elicited epididymo-orchitis and is responsible for damage of rat testis.Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis.Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.Attenuation of human neutrophil migration and function by uropathogenic bacteria.Expression and antimicrobial function of beta-defensin 1 in the lower urinary tractSoxS increases the expression of the zinc uptake system ZnuACB in an Escherichia coli murine pyelonephritis model.Role of Uropathogenic Escherichia coli Virulence Factors in Development of Urinary Tract Infection and Kidney Damage.Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladderAssociation of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.Development of a Vaccine against Escherichia coli Urinary Tract Infections.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coliLipopolysaccharide Domains Modulate Urovirulence.OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis.Novel immunotherapeutic strategies for pyelonephritis.Therapies in early development for the treatment of urinary tract inflammation.Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the hostExpression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.Haemophilus parainfluenzae has a limited core lipopolysaccharide repertoire with no phase variation.Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields.Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells.Interleukin-6/Stat3 signaling has an essential role in the host antimicrobial response to urinary tract infection.
P2860
Q26770272-890D94C2-D176-4795-913A-712566952459Q27028174-E2A69A3A-19D8-45EE-B0D4-F8FA01EF6097Q30381843-D44870AD-0D2C-4CBF-8E55-1FDF05DCEAE6Q31085840-10C0CA73-5D1A-48F7-B59C-62B2730DD548Q33573373-CA0383AC-E5B4-4BF0-8D96-70BFBD87E9ADQ33613902-D705E97E-2CB4-4BB0-904D-AB3EE58754CAQ33736787-E863DC34-1E1C-4552-8713-F59297A0BA49Q33850497-1A472EAB-4155-4A0F-960A-22E785492817Q34026223-5E94EB7B-BAAF-408A-9493-D51B973C9E0AQ34505744-50A3BEF0-2486-47A5-B798-DD005C267CDDQ34535160-547F0C48-EBEA-4839-9437-2C43B04598C6Q34542226-48C34622-1647-4B0A-ADD3-9FB88C0BE4C6Q34546729-8620886C-D15B-45C4-9488-C697A383E313Q34641267-E8A8BA3C-4FF6-4C44-8184-6696F0BAED95Q34975465-7388E124-208F-4972-81E7-24A2BB87278DQ35035519-3E8F79A3-136D-436C-AA5E-C8A264939912Q35805974-9BC9702D-6DC7-400E-BC78-DB0C6479605FQ35852635-EA9B49D1-DB12-4F9F-8776-26CF2C78FA2BQ36154064-497D54AC-CFD6-46FB-AD81-54B0EF7088EBQ36506173-63AAAB45-17C7-4652-A54D-5DA209BE8195Q36634934-05D0AA4E-93B0-4660-A8AB-DCBE1A85B299Q36735378-826B0843-F3B8-490D-ACB9-64F93A96AD9EQ36910650-AEB9C663-0E40-4505-81E9-ABB36BBC201DQ37256577-6B3D4D0D-85D5-4F0F-891D-51634790DFCEQ37345901-E5DC5AB0-4062-431C-8461-89744B5F20F6Q37451212-D028BBDE-620C-4578-986A-C60644F81D2CQ38660795-3E120070-CFA4-4800-8FCF-A097E2EEE109Q38757968-7276EB29-B5E7-4F35-A681-2116E1829CF0Q39879434-C489AEFB-D248-4DAF-9C48-1CBA7EC50FD5Q43646743-6BEC8F72-9228-4D85-B4CF-0DAE10E8F212Q46471744-1F4EF55D-231D-41B3-A6C2-91E718603A6AQ47711163-44CA9225-A67D-4E91-B3A4-27B4228ED06DQ51891134-C588B582-CAB2-4D1F-AD5F-8E8B7CA88A12Q52730724-147A3A62-DEE2-4D18-BBE4-BE30F8AF5C37
P2860
Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Molecular basis of uropathogen ...... mmune response in the bladder.
@en
type
label
Molecular basis of uropathogen ...... mmune response in the bladder.
@en
prefLabel
Molecular basis of uropathogen ...... mmune response in the bladder.
@en
P2093
P2860
P356
P1476
Molecular basis of uropathogen ...... mmune response in the bladder.
@en
P2093
Anthony J Schaeffer
Benjamin K Billips
David J Klumpp
P2860
P304
P356
10.1128/IAI.00069-08
P407
P577
2008-06-16T00:00:00Z